Lentivector-mediated RNAi efficiently downregulates expression of murine TNF-α gene in vitro and in vivo

Abstract

In order to explore the role of TNF-α in Niemann-Pick type C (NPC) disease, lentiviral-delivered RNA interference (RNAi) was used to silence the expression of murine TNF-α gene in vitro and in npc mice. Interference efficiency of the lentivirus expressing TNF-α-siRNA, previously constructed with the concentration of 2×10⁸ ifu/mL, was determined by RT-PCR and ELISA in BV-2 cells and astrocytes. At the same time, the constructed Lenti-TNF-α-siRNA was intracerebroven-tricularly infused into 4-week old npc mice for a 4-week period, and the mice were divided into 3 groups: Lenti-TNF-α-siRNA (n=6), control lentivirus (n=6), and NPC mice without any intervention (n=4). By using immunohistochemistry and real-time PCR, the down-regulation of the target genes was detected. The Lenti-TNF-α-siRNA downregulated the expression of murine TNF-α gene efficiently in vitro and the interference efficiency was 66.7%. Lentivirus could be expressed stably for long-term in the npc mice brain. Immunohistochemistry and real-time PCR revealed that, as compared with non-intervention group and Lenti-control group, Lenti-TNF-α-siRNA efficiently down-regulated the expression of murine TNF-α gene with the interference efficiency being 66.9%. TNF-α-siRNA down-regulated the expression of TNF-α gene in vitro and in vivo, which provided a potential tool for studying and treating neurodegenerative diseases and TNF-α-related diseases.

Keywords

lentivirus / TNF-α / neurodegenerative disease / RNA interference / npc mice

References

[1] VanierM.T., SuzukiK.. Recent advances in elucidating Niemann-Pick C disease. Brain Pathol, 1998, 8: 163-174

[2] EllederM., JirasekA., SmidF., et al. . Niemann-Pick disease type C. Study on the nature of the cerebral storage process. Acta Neuropathol, 1985, 66: 325-336

[3] GermanD.C., QuinteroE.M., LiangC.L., et al. . Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann-Pick C disease. J Comp Neurol, 2001, 433: 415-425

[4] BuB., KlunemannH., SuzukiK., et al. . Niemann-Pick disease type C yields possible clue for why cerebellar neurons do not form neurofibrillary tangles. Neurobiol Dis, 2002, 11: 285-297

[5] WuY.P., MizukamiH., MatsudaJ., et al. . Apoptosis accompanied by up-regulation of TNF-alpha death pathway genes in the brain of Niemann-Pick type C disease. Mol Genet Metab, 2005, 84(1): 9-17

[6] BezziP., DomercqM., BrambillaL., et al. . CXCR4-activated astrocyte glutamate release via TNF-alpha: amplification by microglia triggers neurotoxicity. Nat Neurosci, 2001, 4(7): 702-710

[7] TobinickE.. Perispinal etanercept for treatment of Alzheimer’s disease. Curr Alzheimer Res, 2007, 4(5): 550-552

[8] ButovskyO., Koronyo-HamaouiM., KunisG., et al. . Glatiramer acetate fights against Alzheimer’s disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc Natl Acad Sci USA, 2006, 103(31): 11 784-11 789

[9] NelsonT.J., AlkonD.L.. Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide. J Biol Chem, 2005, 280(8): 7377-7387

[10] TakeuchiH., JinS., WangJ., et al. . Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem, 2006, 281(30): 21 362-21 368

[11] CulbertA.A., SkaperS.D., HowlettD.R., et al. . MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease. J Biol Chem, 2006, 281(33): 23 658-23 667

[12] AlvarezA., CacabelosR., SanpedroC., et al. . Serum TNF-α levels are increased and correlate negatively with free IGF-I in Alzheimer disease. Neurobiol Aging, 2007, 28(4): 533-536

[13] Smith-AricaJ.R., BartlettJ.S.. Gene therapy: recombinant adeno-associated virus vectors. Curr Cardiol Rep, 2001, 3(1): 43-49

[14] BoviaF., SalmonP., MatthesT., et al. . Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors. Blood, 2003, 101(5): 1727-1733

[15] RubinsonD.A., DillonC.P., KwiatkowskiA.V., et al. . A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet, 2003, 33: 401-406

[16] SørensenD.R., LeirdalM., SioudM.. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol, 2003, 327(4): 761-766